Aurora Spine’s proprietary implant locking technology, covered by U.S. Patent No. 9,603,637 (Polyaxial Interspinous Fusion Implant and Bone Growth Stimulation System), is available for out-licensing or private labeling opportunities.
Leadership notes that the device, with its combination of a ONE-STEP™ locking mechanism and the polyaxial feature, could support new product development for orthopaedic, medical and industrial manufacturers. The technology is FDA-cleared and approved by Health Canada.
Aurora Spine's proprietary implant locking technology, covered by U.S. Patent No. 9,603,637 (Polyaxial Interspinous Fusion Implant and Bone Growth Stimulation System), is available for out-licensing or private labeling opportunities.
Leadership notes that the device, with its combination of a ONE-STEP™ locking mechanism and the...
Aurora Spine’s proprietary implant locking technology, covered by U.S. Patent No. 9,603,637 (Polyaxial Interspinous Fusion Implant and Bone Growth Stimulation System), is available for out-licensing or private labeling opportunities.
Leadership notes that the device, with its combination of a ONE-STEP™ locking mechanism and the polyaxial feature, could support new product development for orthopaedic, medical and industrial manufacturers. The technology is FDA-cleared and approved by Health Canada.
Copy to clipboard 
